| | | | | | | | | | | | | | | | |
| |
 | Issue Date FY: 2025 ( Subtotal = $596,750 ) |
| 2025 | 2025 | THE ROSKAMP INSTITUTE, INC. | 2040 WHITFIELD AVE | SARASOTA | FL | 34243-3922 | MANATEE | USA | R21AG089503 | Influence of microglial cell depletion and repopulation on aducanumab induced ARIA and vascular lesions in APOE4 carriers with AD | 000 | 2 | NIH | 5/2/2025 | $255,750 |
| 2025 | 2025 | THE ROSKAMP INSTITUTE, INC. | 2040 WHITFIELD AVE | SARASOTA | FL | 34243-3922 | MANATEE | USA | R03AG087463 | Targeting the astrocyte-cerebrovasculature system to correct brain bioenergetics defects associated with APOE4 | 000 | 1 | NIH | 12/20/2024 | $341,000 |
| 2025 | 2023 | THE ROSKAMP INSTITUTE, INC. | 2040 WHITFIELD AVE | SARASOTA | FL | 34243-3922 | MANATEE | USA | R03AG075365 | The role of PPARγ in microglia pathobiologyafter exposure to repetitive mild traumatic brain injury | 000 | 2 | NIH | 5/5/2025 | $0 |
|
 | Issue Date FY: 2024 ( Subtotal = $1,735,020 ) |
| 2024 | 2024 | THE ROSKAMP INSTITUTE, INC. | 2040 WHITFIELD AVE | SARASOTA | FL | 34243-3922 | MANATEE | USA | R21AG089503 | Influence of microglial cell depletion and repopulation on aducanumab induced ARIA and vascular lesions in APOE4 carriers with AD | 000 | 1 | NIH | 8/27/2024 | $213,125 |
| 2024 | 2024 | THE ROSKAMP INSTITUTE, INC. | 2040 WHITFIELD AVE | SARASOTA | FL | 34243-3922 | MANATEE | USA | R21AG087181 | Aberrant PTEN signaling in chronically activated microglia drives tau pathology, neurodegeneration and cognitive decline following repetitive brain injury | 000 | 1 | NIH | 6/14/2024 | $449,460 |
| 2024 | 2024 | THE ROSKAMP INSTITUTE, INC. | 2040 WHITFIELD AVE | SARASOTA | FL | 34243-3922 | MANATEE | USA | R01ES036145 | Neurological effects of aerosolized red tide neurotoxins | 000 | 1 | NIH | 8/22/2024 | $704,695 |
| 2024 | 2024 | ROSKAMP INSTITUTE INC, THE | 2040 WHITFIELD AVE | SARASOTA | FL | 34243-3922 | MANATEE | USA | R03AG080415 | Influence of APOE4 genotype on microglial pathobiology and tau pathology after repetitive mTBI | 000 | 2 | NIH | 11/3/2023 | $147,096 |
| 2024 | 2024 | THE ROSKAMP INSTITUTE, INC. | 2040 WHITFIELD AVE | SARASOTA | FL | 34243-3922 | MANATEE | USA | R03AG080415 | Influence of APOE4 genotype on microglial pathobiology and tau pathology after repetitive mTBI | 001 | 2 | NIH | 5/1/2024 | $16,344 |
| 2024 | 2024 | THE ROSKAMP INSTITUTE, INC. | 2040 WHITFIELD AVE | SARASOTA | FL | 34243-3922 | MANATEE | USA | R21NS131162 | The role of adaptive immunity in organophosphate induced CNS injury | 000 | 2 | NIH | 8/20/2024 | $204,300 |
| 2024 | 2022 | THE ROSKAMP INSTITUTE, INC. | 2040 WHITFIELD AVE | SARASOTA | FL | 34243-3922 | MANATEE | USA | R03AG070540 | The effects of APOE4 on carnitine/acylcarnitine mediated bioenergetic deficits in Alzheimer's disease | 000 | 2 | NIH | 4/10/2024 | $0 |
| 2024 | 2022 | THE ROSKAMP INSTITUTE, INC. | 2040 WHITFIELD AVE | SARASOTA | FL | 34243-3922 | MANATEE | USA | R03AG073829 | Influence of APOE genotype on cerebrovascular cell pathobiology in AD, and the contribution of microglia inflammation | 000 | 2 | NIH | 7/16/2024 | $0 |
| 2024 | 2021 | THE ROSKAMP INSTITUTE, INC. | 2040 WHITFIELD AVE | SARASOTA | FL | 34243-3922 | MANATEE | USA | R21ES032114 | Long term assessment of neurological effects after red tide exposure | 000 | 2 | NIH | 1/2/2024 | $0 |
|
 | Issue Date FY: 2023 ( Subtotal = $1,658,344 ) |
| 2023 | 2023 | ROSKAMP INSTITUTE INC, THE | 2040 WHITFIELD AVE | SARASOTA | FL | 34243-3922 | MANATEE | USA | R03AG080415 | Influence of APOE4 genotype on microglial pathobiology and tau pathology after repetitive mTBI | 000 | 1 | NIH | 11/30/2022 | $163,440 |
| 2023 | 2023 | ROSKAMP INSTITUTE INC, THE | 2040 WHITFIELD AVE | SARASOTA | FL | 34243-3922 | MANATEE | USA | R03AG075365 | The role of PPARγ in microglia pathobiologyafter exposure to repetitive mild traumatic brain injury | 000 | 2 | NIH | 2/1/2023 | $163,439 |
| 2023 | 2023 | ROSKAMP INSTITUTE INC, THE | 2040 WHITFIELD AVE | SARASOTA | FL | 34243-3922 | MANATEE | USA | R21AG080375 | Cerebrovascular contributions to APOE4-mediated brain bioenergetic deficits in Alzheimer's disease | 000 | 1 | NIH | 8/18/2023 | $449,460 |
| 2023 | 2023 | ROSKAMP INSTITUTE INC, THE | 2040 WHITFIELD AVE | SARASOTA | FL | 34243-3922 | MANATEE | USA | R21AG080661 | The role of PPAR? in astrocyte pathobiology after exposure to repetitive mild traumatic brain injury | 000 | 1 | NIH | 8/23/2023 | $449,444 |
| 2023 | 2023 | ROSKAMP INSTITUTE INC, THE | 2040 WHITFIELD AVE | SARASOTA | FL | 34243-3922 | MANATEE | USA | R21NS131162 | The role of adaptive immunity in organophosphate induced CNS injury | 000 | 1 | NIH | 8/31/2023 | $244,269 |
| 2023 | 2023 | ROSKAMP INSTITUTE INC, THE | 2040 WHITFIELD AVE | SARASOTA | FL | 34243-3922 | MANATEE | USA | R03AG078772 | THE ROLE OF PTEN IN MICROGLIAL PATHOBIOLOGY AFTER EXPOSURE TO REPETITIVE MILD TBI | 000 | 2 | NIH | 8/4/2023 | $163,440 |
| 2023 | 2022 | ROSKAMP INSTITUTE INC, THE | 2040 WHITFIELD AVE | SARASOTA | FL | 34243-3922 | MANATEE | USA | R03AG073829 | Influence of APOE genotype on cerebrovascular cell pathobiology in AD, and the contribution of microglia inflammation | 000 | 2 | NIH | 7/21/2023 | $0 |
| 2023 | 2020 | ROSKAMP INSTITUTE INC, THE | 2040 WHITFIELD AVE | SARASOTA | FL | 34243-3922 | MANATEE | USA | R21AI142717 | Application of lipidomics to identify biomarkers of immune and mitochondrial disturbances in Chronic Fatigue Syndrome. | 000 | 2 | NIH | 4/27/2023 | $24,852 |
| 2023 | 2020 | ROSKAMP INSTITUTE INC, THE | 2040 WHITFIELD AVE | SARASOTA | FL | 34243-3922 | MANATEE | USA | R01NS092610 | PATHOBIOLOGICAL STUDIES OF VESSEL BACE1 IN CEREBROVASCULAR AMYLOID ANGIOPATHY | 000 | 5 | NIH | 9/12/2023 | $0 |
|
 | Issue Date FY: 2022 ( Subtotal = $626,018 ) |
| 2022 | 2022 | ROSKAMP INSTITUTE INC, THE | 2040 WHITFIELD AVE | SARASOTA | FL | 34243-3922 | MANATEE | USA | R03AG070540 | The effects of APOE4 on carnitine/acylcarnitine mediated bioenergetic deficits in Alzheimer's disease | 001 | 2 | NIH | 6/9/2022 | $16,200 |
| 2022 | 2022 | ROSKAMP INSTITUTE INC, THE | 2040 WHITFIELD AVE | SARASOTA | FL | 34243-3922 | MANATEE | USA | R03AG075365 | The role of PPARγ in microglia pathobiologyafter exposure to repetitive mild traumatic brain injury | 000 | 1 | NIH | 1/27/2022 | $163,439 |
| 2022 | 2022 | ROSKAMP INSTITUTE INC, THE | 2040 WHITFIELD AVE | SARASOTA | FL | 34243-3922 | MANATEE | USA | R03AG070540 | The effects of APOE4 on carnitine/acylcarnitine mediated bioenergetic deficits in Alzheimer's disease | 000 | 2 | NIH | 2/16/2022 | $145,800 |
| 2022 | 2022 | ROSKAMP INSTITUTE INC, THE | 2040 WHITFIELD AVE | SARASOTA | FL | 34243-3922 | MANATEE | USA | R03AG078772 | THE ROLE OF PTEN IN MICROGLIAL PATHOBIOLOGY AFTER EXPOSURE TO REPETITIVE MILD TBI | 000 | 1 | NIH | 8/12/2022 | $163,440 |
| 2022 | 2022 | ROSKAMP INSTITUTE INC, THE | 2040 WHITFIELD AVE | SARASOTA | FL | 34243-3922 | MANATEE | USA | R03AG073829 | Influence of APOE genotype on cerebrovascular cell pathobiology in AD, and the contribution of microglia inflammation | 000 | 2 | NIH | 7/15/2022 | $161,991 |
| 2022 | 2020 | ROSKAMP INSTITUTE INC, THE | 2040 WHITFIELD AVE | SARASOTA | FL | 34243-3922 | MANATEE | USA | R03NS115019 | Effect of Mild TBI on Female Mice with a Controlled Estrous Cycle | 000 | 1 | NIH | 3/21/2022 | $0 |
| 2022 | 2020 | ROSKAMP INSTITUTE INC, THE | 2040 WHITFIELD AVE | SARASOTA | FL | 34243-3922 | MANATEE | USA | R03NS106629 | Development of Neural Stem Cell mediated therapy for repetitive mild TBI. | 000 | 2 | NIH | 6/29/2022 | $0 |
| 2022 | 2020 | ROSKAMP INSTITUTE INC, THE | 2040 WHITFIELD AVE | SARASOTA | FL | 34243-3922 | MANATEE | USA | R21AI142717 | Application of lipidomics to identify biomarkers of immune and mitochondrial disturbances in Chronic Fatigue Syndrome. | 000 | 2 | NIH | 5/26/2022 | -$24,852 |
| 2022 | 2020 | ROSKAMP INSTITUTE INC, THE | 2040 WHITFIELD AVE | SARASOTA | FL | 34243-3922 | MANATEE | USA | R01NS092610 | PATHOBIOLOGICAL STUDIES OF VESSEL BACE1 IN CEREBROVASCULAR AMYLOID ANGIOPATHY | 000 | 5 | NIH | 10/28/2021 | $0 |
| 2022 | 2020 | ROSKAMP INSTITUTE INC, THE | 2040 WHITFIELD AVE | SARASOTA | FL | 34243-3922 | MANATEE | USA | R01NS092610 | PATHOBIOLOGICAL STUDIES OF VESSEL BACE1 IN CEREBROVASCULAR AMYLOID ANGIOPATHY | 000 | 5 | NIH | 10/28/2021 | $0 |
|
 | Issue Date FY: 2021 ( Subtotal = $514,091 ) |
| 2021 | 2021 | ROSKAMP INSTITUTE INC, THE | 2040 WHITFIELD AVE | SARASOTA | FL | 34243-3922 | MANATEE | USA | R03AG070540 | The effects of APOE4 on carnitine/acylcarnitine mediated bioenergetic deficits in Alzheimer's disease | 000 | 1 | NIH | 3/11/2021 | $162,000 |
| 2021 | 2021 | ROSKAMP INSTITUTE INC, THE | 2040 WHITFIELD AVE | SARASOTA | FL | 34243-3922 | MANATEE | USA | R21ES032114 | Long term assessment of neurological effects after red tide exposure | 000 | 2 | NIH | 4/29/2021 | $190,100 |
| 2021 | 2021 | ROSKAMP INSTITUTE INC, THE | 2040 WHITFIELD AVE | SARASOTA | FL | 34243-3922 | MANATEE | USA | R03AG073829 | Influence of APOE genotype on cerebrovascular cell pathobiology in AD, and the contribution of microglia inflammation | 000 | 1 | NIH | 8/11/2021 | $161,991 |
| 2021 | 2019 | ROSKAMP INSTITUTE INC, THE | 2040 WHITFIELD AVE | SARASOTA | FL | 34243-3922 | MANATEE | USA | R56NS112166 | Influence of APOE Genotype on the neurodegenerative sequelae of repetitive mild TBI in an hTau mouse model. | 000 | 1 | NIH | 5/21/2021 | $0 |
|
 | Issue Date FY: 2020 ( Subtotal = $1,063,854 ) (Continued on the next page) |
| 2020 | 2020 | ROSKAMP INSTITUTE INC, THE | 2040 WHITFIELD AVE | SARASOTA | FL | 34243-3922 | MANATEE | USA | R03NS106629 | Development of Neural Stem Cell mediated therapy for repetitive mild TBI. | 001 | 2 | NIH | 2/10/2020 | $8,000 |
| 2020 | 2020 | ROSKAMP INSTITUTE INC, THE | 2040 WHITFIELD AVE | SARASOTA | FL | 34243-3922 | MANATEE | USA | R03NS106629 | Development of Neural Stem Cell mediated therapy for repetitive mild TBI. | 000 | 2 | NIH | 11/28/2019 | $72,000 |
| 2020 | 2020 | ROSKAMP INSTITUTE INC, THE | 2040 WHITFIELD AVE | SARASOTA | FL | 34243-3922 | MANATEE | USA | R01NS092610 | PATHOBIOLOGICAL STUDIES OF VESSEL BACE1 IN CEREBROVASCULAR AMYLOID ANGIOPATHY | 001 | 5 | NIH | 9/22/2020 | $350,000 |
| 2020 | 2020 | ROSKAMP INSTITUTE INC, THE | 2040 WHITFIELD AVE | SARASOTA | FL | 34243-3922 | MANATEE | USA | R01NS092610 | PATHOBIOLOGICAL STUDIES OF VESSEL BACE1 IN CEREBROVASCULAR AMYLOID ANGIOPATHY | 001 | 5 | NIH | 9/22/2020 | $50,000 |
| 2020 | 2020 | ROSKAMP INSTITUTE INC, THE | 2040 WHITFIELD AVE | SARASOTA | FL | 34243-3922 | MANATEE | USA | R21AI142717 | Application of lipidomics to identify biomarkers of immune and mitochondrial disturbances in Chronic Fatigue Syndrome. | 000 | 2 | NIH | 11/26/2019 | $197,454 |
| 2020 | 2020 | ROSKAMP INSTITUTE INC, THE | 2040 WHITFIELD AVE | SARASOTA | FL | 34243-3922 | MANATEE | USA | R03NS115019 | Effect of Mild TBI on Female Mice with a Controlled Estrous Cycle | 001 | 1 | NIH | 9/14/2020 | $81,000 |
| 2020 | 2020 | ROSKAMP INSTITUTE INC, THE | 2040 WHITFIELD AVE | SARASOTA | FL | 34243-3922 | MANATEE | USA | R21ES032114 | Long term assessment of neurological effects after red tide exposure | 000 | 1 | NIH | 5/1/2020 | $224,400 |
| 2020 | 2020 | ROSKAMP INSTITUTE INC, THE | 2040 WHITFIELD AVE | SARASOTA | FL | 34243-3922 | MANATEE | USA | R03NS115019 | Effect of Mild TBI on Female Mice with a Controlled Estrous Cycle | 000 | 1 | NIH | 12/13/2019 | $81,000 |
| 2020 | 2019 | ROSKAMP INSTITUTE INC, THE | 2040 WHITFIELD AVE | SARASOTA | FL | 34243-3922 | MANATEE | USA | R01NS092610 | PATHOBIOLOGICAL STUDIES OF VESSEL BACE1 IN CEREBROVASCULAR AMYLOID ANGIOPATHY | 000 | 4 | NIH | 1/15/2020 | $0 |
|